爱尔眼科
(300015)
| 流通市值：1187.50亿 | | | 总市值：1399.99亿 |
| 流通股本：79.11亿 | | | 总股本：93.27亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 16,301,500,342.75 | 10,545,229,547.24 | 5,196,134,001.26 | 20,367,156,738.96 |
| 营业收入 | 16,301,500,342.75 | 10,545,229,547.24 | 5,196,134,001.26 | 20,367,156,738.96 |
| 二、营业总成本 | 12,268,216,804.7 | 8,156,999,586.73 | 4,021,509,579.51 | 15,113,233,328.74 |
| 营业成本 | 7,984,744,713.2 | 5,331,661,022.88 | 2,686,758,916.8 | 10,021,974,992.54 |
| 税金及附加 | 44,118,998.03 | 27,022,910.8 | 13,282,926.82 | 48,621,082.36 |
| 销售费用 | 1,640,037,750.51 | 1,120,052,979.17 | 485,817,611.88 | 1,966,310,204.99 |
| 管理费用 | 2,225,346,478.18 | 1,425,762,350.84 | 699,051,373.06 | 2,669,210,599.3 |
| 研发费用 | 233,150,517.78 | 148,641,766.55 | 74,654,886.82 | 333,488,746.98 |
| 财务费用 | 140,818,347 | 103,858,556.49 | 61,943,864.13 | 73,627,702.57 |
| 其中:利息费用 | 184,652,799.88 | 120,387,467.06 | 56,356,681.76 | 194,823,311.92 |
| 其中:利息收入 | 76,032,588.72 | 53,985,575.03 | 27,159,683.87 | 119,205,074.7 |
| 加:公允价值变动收益 | 214,300,608.2 | 170,025,596.68 | -3,078,157.94 | -79,423,438.27 |
| 加:投资收益 | 148,922,310.66 | 84,800,202.12 | 1,823,265.17 | 46,523,296.64 |
| 资产处置收益 | 3,959,688.25 | 5,631,246.45 | 2,621,794.56 | 710,786.81 |
| 资产减值损失(新) | -560,450.44 | -573,862.98 | - | -383,606,484.38 |
| 信用减值损失(新) | -58,350,296.17 | -25,378,880.86 | -27,679,366.74 | -111,211,902.88 |
| 其他收益 | 102,272,589.9 | 92,541,661.23 | 85,081,860.24 | 221,031,114 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 4,443,827,988.45 | 2,715,275,923.15 | 1,233,393,817.04 | 4,947,946,782.14 |
| 加:营业外收入 | 9,976,995.69 | 3,946,936.94 | 2,875,713.37 | 12,033,022.64 |
| 减:营业外支出 | 105,977,189.17 | 59,757,511.74 | 33,662,125.81 | 408,961,193.95 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 4,347,827,794.97 | 2,659,465,348.35 | 1,202,607,404.6 | 4,551,018,610.83 |
| 减:所得税费用 | 679,621,278.09 | 450,761,481.29 | 230,193,496.6 | 895,023,069.93 |
| 六、净利润 | 3,668,206,516.88 | 2,208,703,867.06 | 972,413,908 | 3,655,995,540.9 |
| 持续经营净利润 | 3,668,206,516.88 | 2,208,703,867.06 | 972,413,908 | 3,655,995,540.9 |
| 归属于母公司股东的净利润 | 3,451,768,879.59 | 2,049,880,847.74 | 899,476,291.54 | 3,358,871,535.71 |
| 少数股东损益 | 216,437,637.29 | 158,823,019.32 | 72,937,616.46 | 297,124,005.19 |
| (一)基本每股收益 | 0.37 | 0.22 | 0.1 | 0.36 |
| (二)稀释每股收益 | 0.37 | 0.22 | 0.1 | 0.36 |
| 八、其他综合收益 | -3,449,938.8 | -54,894,343.19 | -34,939,834.55 | 48,821,772 |
| 归属于母公司股东的其他综合收益 | -10,855,829.74 | -54,724,918.78 | -34,182,908.03 | 52,840,307.14 |
| 九、综合收益总额 | 3,664,756,578.08 | 2,153,809,523.87 | 937,474,073.45 | 3,704,817,312.9 |
| 归属于母公司股东的综合收益总额 | 3,440,913,049.85 | 1,995,155,928.96 | 865,293,383.51 | 3,411,711,842.85 |
| 归属于少数股东的综合收益总额 | 223,843,528.23 | 158,653,594.91 | 72,180,689.94 | 293,105,470.05 |
| 公告日期 | 2024-10-31 | 2024-08-24 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |